Lynch Ryan 4
4 · CONCERT PHARMACEUTICALS, INC. · Filed Sep 18, 2017
Insider Transaction Report
Form 4
Lynch Ryan
PFO, PAO
Transactions
- Sale
Common Stock
2017-09-14$14.51/sh−3,500$50,785→ 6,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-09-14−3,500→ 3,200 totalExercise: $9.46Exp: 2024-06-11→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2017-09-14$9.46/sh+3,500$33,110→ 9,500 total
Footnotes (1)
- [F1]Twenty five percent (25%) of the shares subject to this option vested on June 12, 2015, and the option vested and will continue to vest in equal quarterly installments thereafter, until June 12, 2018, at which time this option will be fully vested.